US Stock MarketDetailed Quotes

BCRX BioCryst Pharmaceuticals

Watchlist
  • 9.390
  • +0.030+0.32%
Close Feb 19 16:00 ET
  • 9.390
  • 0.0000.00%
Post 20:01 ET
1.94BMarket Cap-15.39P/E (TTM)

BioCryst Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BioCryst Pharmaceuticals Q4 2024 Estimates Date

Currency：USDFeb 24, 2025

Estimate YoY
Revenue
131.10M
+40.36%
EPS
-0.05
+82.38%
Analyst Rating
Strong Buy

Feb 5, 2025

BioCryst Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 126.636M--
Feb 24, 20252024/Q4-- / 131.101M--
Nov 4, 20242024/Q3117.085M / 112.666M--
Aug 5, 20242024/Q2109.332M / 98.324M--
May 6, 20242024/Q192.761M / 85.505M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 126.636M--
Feb 24, 20252024/Q4-- / 131.101M--
Nov 4, 20242024/Q3117.085M / 112.666M--
Aug 5, 20242024/Q2109.332M / 98.324M--
May 6, 20242024/Q192.761M / 85.505M--

Unlock Free Earnings Estimates

BioCryst Pharmaceuticals Earnings Reports

  • BioCryst Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 5, 2024 17:21 ET

  • BioCryst Pharmaceuticals | 8-K: BioCryst Reports Third Quarter 2024 Financial Results and Provides Business Update

    Nov 4, 2024 07:09 ET

  • BioCryst Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 6, 2024 16:09 ET

  • BioCryst Pharmaceuticals | 8-K: BioCryst Reports Second Quarter 2024 Financial Results and Provides Business Update

    Aug 5, 2024 07:08 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Hutchmed (China)
    HCM
    +8.09%
    Constellation Brands
    STZ
    +1.79%
    Collegium Pharmaceutical
    COLL
    +0.67%
    Enerpac Tool
    EPAC
    +0.60%
    Ermenegildo Zegna NV
    ZGN
    0.00%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 5, 2025

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data